全球骨科企业大数据发布，12家中国企业挺进百强！

admin

                    

                    

                    
                    
                    <section data-role="paragraph" data-color="rgb(182, 228, 253)" data-custom="rgb(182, 228, 253)"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section><p><p><img src="image/20201014/86b79d371e9862b01189f0252a03b2cd_1.png" /></p></p></section><section><section><span><strong></strong></span></section><p><span>医疗器械媒体报道先锋</span></p><p><span>分享专业医疗器械知识</span></p></section><section><section><section><span>关注</span></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section><section><br  /></section><section><span>在分析了全球上千家骨科相关企业的公开资料后，骨科大数据编辑部（OBDE）将百强企业按自有品牌骨科工商业总营收（考虑到海外企业有很大部分为直营模式，故有别于国内排名只统计工业产值，全球排名记入工业和商业销售的总收入）作为排名依据，将全球百强划分为三个层级：</span><span>第一集团是以强生为代表的30亿美元以上的传统5巨头，以近300亿美元的总营收占据了全行业512亿美元58%的市场份额；</span><span>第二集团为2亿美元以上的22个细分行业领军企业以114亿美元占据22%的市场份额；</span><span>第三集团为2000万美元以上的具有区域影响力的73家小巨人企业以50亿美元占据10%的市场份额；</span><span>百强企业总体以460多亿美元的规模占据了全行业90%的市场份额，其余近千家中小企业和初创企业分享剩余的10%。</span><span></span><span></span></section><p><br  /></p><section><span>可喜的是我们看到有12家中国企业入围了本年度世界百强名单，特别是纳通集团（凭借强大的专业市场服务能力，总营收遥遥领先国内同行，考虑其对部分代理品牌有强大的控制力，我们取其总营收的一半作为排名数据）和上海微创骨科（凭借对海外著名企业的友好收购）已经率先突入全球第二集团，这些企业或者已经上市，或者已经在上市的路上，或者也有如华为一样，强大却坚持不上市的，由衷的祝贺他们，同时我们也希望未来有更多的中国企业入围。</span><span></span></section><p><br  /></p><section><span>-------------------------------------</span><br  /></section><section><span>▼▼▼</span></section><section><span><strong><span>【 国际第一集团：</span></strong></span><span><strong><span>五巨头 】</span></strong></span><strong><span></span></strong><span></span></section><section><br  /></section><section><p><img src="image/20201014/c4867416c336124f34ce36bcab3d40fb_2.jpg" /></p></section><section><p><img src="image/20201014/231f8bf5c95568530b6a0ae7d34cb3fa_3.jpg" /></p></section><section><br  /></section><section><span>营收单位“亿美元”</span><span></span></section><section></section><section></section><section><p><img src="image/20201014/451c1a05f52b4e178c088b71d0a17113_4.jpg" /></p><br  /></section><section><br  /></section><section><span>传统势力均等的7大行业巨头经过整合，已经进入实力落差较大的5巨头时代：</span></section><section><span><br  /></span></section><section><span>◆&nbsp;强生自收购辛迪斯后长期处于行业第一位置，虽然近年略有萎缩，但仍旧以88亿美元营收牢牢占据骨科状元宝座，创伤产品更是以40%以上的市场份额遥遥领先同行；</span></section><section><span><br  /></span></section><section><span>◆&nbsp;捷迈邦美合并后也是长期位于第二位置，但地位摇摇欲坠，很有可能来年会被史赛克超越，大关节产品是捷迈邦美的强项，始终占据行业第一位置，实力强劲，不可动摇；</span></section><section><span><br  /></span></section><section><span>◆&nbsp;探花史赛克近年增长耀眼，不仅骨科业务扶摇直上直逼榜眼，整体实力也是突飞猛进，正在向医疗器械行业老三发起冲击；</span></section><section><span><br  /></span></section><section><span>◆ 5大里唯一的非美国企业，大英帝国的荣耀，老四施乐辉由于缺乏脊柱产品线，故整体实力稍弱，但最近有报告称正在洽购脊柱行业当红炸子鸡Nuvasive似乎是想补足短板；</span></section><section><span><br  /></span></section><section><span>◆&nbsp;老五美敦力，长期在脊柱产品线处于独孤求败的位置，但骨科整体实力已经明显跟不上第一梯队，和自己医疗器械第一巨头的位置实在不符，且脊柱份额也在大幅度的被新进企业蚕食，眼巴巴的让各位看官心里直焦急，为何还不与自己天然互补的老四合并，凑成实力均等的新四大已经成为行业内共同的期待。</span></section><section><span>5大近年共同的特点是都在大力发展骨科机器人业务，分别收购了至少一家以上行业领先的独立机器人公司，未来智能化和精准微创化已经是明显的行业趋势。</span><span></span></section><p><br  /></p><section><span>-------------------------------------</span><br  /></section><section><span>▼▼▼</span></section><section><strong><span>【 国际第二集团：</span></strong><strong><span>细分行业领军企业&nbsp;】</span></strong><strong><span></span></strong><span></span></section><section><strong><span><br  /></span></strong></section><section></section><section></section><section><p><img src="image/20201014/7fbcb083a028b44aba29748b0f5c9ce5_5.jpg" /></p></section><section><p><img src="image/20201014/83f40010a865c1ffc0f87b72804d31bb_6.jpg" /></p></section><section><p><img src="image/20201014/e85662551b8ad33d09f362fa26b0bc8b_7.jpg" /></p></section><section><p><img src="image/20201014/7f3fd51f591fc65ad3fe686a9c854cc5_8.jpg" /></p></section><section><br  /></section><section><span>营收单位“亿美元”</span><span></span><br  /></section><section></section><section></section><section><p><img src="image/20201014/6fe4307ab5e862a907f9be49d6f17dce_9.jpg" /></p></section><section><p><img src="image/20201014/27551c340afa71e7eea2e310ae63b356_10.jpg" /></p></section><section><br  /></section><section><span>第二集团22家2亿美元营收以上的企业基本上都是各个细分行业的前三名领军企业：</span><span>如Arthrex是运动医学的老大，NuVasive是最大独立脊柱企业，Wright是手足产品的领头羊等等；</span><span>专注于某一细分行业几乎是这个层级企业最大的特点，这也提醒我们国内的企业，发展过程中不一定要过分追求大而全小而全，有时候静下心来专注于某一细分品类也会有好的发展。</span><span></span></section><p><br  /></p><section><span>-------------------------------------</span><br  /></section><section><span>▼▼▼</span></section><section><strong><span>【 国际第三集团：</span></strong><strong><span>2000万美元以上小巨人&nbsp;】</span></strong><strong><span></span></strong><span></span></section><section><br  /></section><section><p><img src="image/20201014/c31773498d298d207dd5019811d472c9_11.jpg" /></p></section><section><p><img src="image/20201014/716db5f18bd325263b764e5bf20d148d_12.jpg" /></p></section><section><p><img src="image/20201014/a45603592ecc11e81593772af3f55ced_13.jpg" /></p></section><section><p><img src="image/20201014/e60d7a5d18f478dee5752bd9586df44a_14.jpg" /></p></section><section><br  /></section><section>营收单位“亿美元”<br  /></section><section><p><img src="image/20201014/49655abd6b38943ecaefeeb932e1eda4_15.jpg" /></p></section><section><p><img src="image/20201014/87168286e88dbf7f297960d4d407b66d_16.jpg" /></p></section><section><br  /></section><section><p><img src="image/20201014/2e74896894224f84de9d7fb950f6d15a_17.jpg" /></p></section><section><p><img src="image/20201014/21ac877c44946040d0a988cb8d5894c1_18.jpg" /></p></section><section><p><img src="image/20201014/67e8fbbd6bd8996576d0a7e5b764a780_19.jpg" /></p></section><section><p><img src="image/20201014/d592c7a87728b5d92cbed7b604a43aa2_20.jpg" /></p></section><section><br  /></section><section>营收单位“亿美元”</section><section><p><img src="image/20201014/4ee9a5c39456a8042f1439a425846f92_21.jpg" /></p></section><section><p><img src="image/20201014/54f1a145cf3c3d48d20b363797294841_22.jpg" /></p></section><section><br  /></section><section><p><img src="image/20201014/a01986d913ddacce8044d6903b075756_23.jpg" /></p><br  /></section><section><p><img src="image/20201014/fa87b32bce2fe1fee87fd5cdb335bd51_24.jpg" /></p></section><section><p><img src="image/20201014/3838b422f7bf2dae79b2a307d5cc9cb2_25.jpg" /></p></section><section><p><img src="image/20201014/e61ff4cc5ed2cbd5db1da173d3087148_26.jpg" /></p></section><section><br  /></section><section><span>营收单位“亿美元”</span></section><section><p><img src="image/20201014/c7ac165c173d915e35be219e53a0424a_27.jpg" /></p></section><section><p><img src="image/20201014/9c72cf0f1c501f3de1220e488be42306_28.jpg" /></p></section><section></section><section></section><section><br  /></section><section><span>这一层级的企业大致分为三类：</span><span>一类是美国的创新产品企业，以某一特色创新产品为主打；</span><span>第二类是欧洲日韩等发达国家的公司，在本国或一定区域内有一定的影响力；</span><span>第三类是以中国为代表的新兴国家力量，基本是以综合性产品线全线发展为主，高速成长中。</span></section><p><br  /></p><section><span>文章来源：</span><span>Bone打听</span></section><p><span>转载请注明以上来源</span><span></span></p><p><br  /></p><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph" data-color="#757576"><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph" data-color="#757576"><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph" data-color="#757576"><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph" data-color="#757576"><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph" data-color="#757576"><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph" data-color="#757576"><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph" data-color="#757576"><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph" data-color="#757576"><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph" data-color="#757576"><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph"><section><a data-miniprogram-appid="wxdc7efe409d688f37" data-miniprogram-path="pages/authorizationLogin/authorizationLogin" data-miniprogram-nickname="" href="" data-miniprogram-type="image" data-miniprogram-servicetype="" href=""><p><img src="image/20201014/2e25c809fffd6ef0866d70b58effc1a6_29.gif" /></p></a></section><section><br  /></section><section powered-by="gulangu"><section powered-by="gulangu"><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph"><section><section><section data-brushtype="text"><strong>相关阅读</strong></section></section></section><section><section></section></section><section data-width="100%"><section><section><section><section data-width="100%"><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><section><p><img src="image/20201014/2aac877ff9233ba5a66e7a5ff3a4febf_30.gif" /></p></section><section data-brushtype="text">戳一下，更有料！</section></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><section data-brushtype="text"><br  /></section></section><p><span>盘点！2018年全球10大骨科医疗器械公司</span><br  /></p><p><br  /></p><p><span>200亿元的大手笔收购，全球骨科市场面临洗牌！</span><br  /></p></section></section></section></section></section></section></section></section></section><p><br  /></p></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section><p><p><img src="image/20201014/cd6e6da350853c459044672a7cf353fb_31.jpg" /></p></p>